Home › Research › Prevention and risk
Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease
Berger T, Lee H, Young AH, Aarsland D, Thuret S.. Trends in molecular medicine, 2020-05-14
Topic: Brain proteins, microglia and lab models
Plain-language summary
Depression and dementia are major public health problems. Major depressive disorder (MDD) and Alzheimer's disease (AD) reciprocally elevate the risk for one another. No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance. The biological connection between MDD and AD is still unclear. Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare. Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD. We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD.
What this study adds
Evidence grade: Low
This is a narrative review. This review discusses the role of adult hippocampal neurogenesis as a possible shared mechanism linking major depressive disorder and Alzheimer's disease. It states that no effective drug is available to treat Alzheimer's disease and that the biological connection between depression and Alzheimer's disease remains unclear.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Berger, T., Lee, H., Young, A. H., Aarsland, D., & Thuret, S. (2020). Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease. Trends in molecular medicine. https://doi.org/10.1016/j.molmed.2020.03.010
Vancouver
Berger T, Lee H, Young AH, Aarsland D, Thuret S. Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease. Trends in molecular medicine. 2020. doi:10.1016/j.molmed.2020.03.010. PMID: 32418723.
BibTeX
@article{berger2020-32418723,
author = {Berger, T. and Lee, H. and Young, A. H. and Aarsland, D. and Thuret, S.},
title = {{Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease}},
journal = {Trends in molecular medicine},
year = {2020},
doi = {10.1016/j.molmed.2020.03.010},
pmid = {32418723},
url = {https://doi.org/10.1016/j.molmed.2020.03.010}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- No effective drug is available to treat AD and about one-third of depressive patients show treatment resistance.
- The biological connection between MDD and AD is still unclear.
- Uncovering this link might open novel ways of treatment and prevention to improve patient healthcare.
- Here, we discuss recent studies specifically on the role of human adult hippocampal neurogenesis (AHN) in MDD and AD.
- We compare diverse approaches to analyse the effect of MDD and AD on human AHN and analyse different studies implicating the role of human AHN as a potential converging mechanism in MDD and AD.
Why it matters
This review discusses the role of adult hippocampal neurogenesis as a possible shared mechanism linking major depressive disorder and Alzheimer's disease. It states that no effective drug is available to treat Alzheimer's disease and that the biological connection between depression and Alzheimer's disease remains unclear.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Trends in molecular medicine) |
| Journal's citation record | 2 / 4 | Trends in Molecular Medicine: journal h-index 238 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 207 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 25.9 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 3 / 6 | Cited 4.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 3 / 4 | Cited 110 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sandrine Thuret: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | King's College London: institution h-index 1,348 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32418723) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Prevention and risk from nearby years
Also tagged “disorder”
492 studies in the library carry the topic tag “disorder”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 492 tagged studies.